Protagonist Therapeutics PTG-300 Opportunity Update Webinar
Please join Protagonist Therapeutics (PTGX) for a PTG-300 Opportunity Update Webinar to discuss PTG-300 and its potential in patients with polycythemia vera. Event details including the KOL speakers can be found below.
Srdan Verstovsek, MD, PhD
Director, Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms
MD Anderson Cancer Center
Ronald Hoffman, MD
Director of the Myeloproliferative Diseases Program
The Icahn School of Medicine at Mount Sinai